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Introduction: Electrical velocimetry (EV) is a type of impedance cardiography, and is a non-invasive and
continuously applicable method of cardiac output monitoring. Transthoracic echocardiography (TTE) is non-invasive
but discontinuous.
Methods: We compared EV with TTE in pediatric intensive care patients in a prospective single-center observational
study. Simultaneous, coupled, left ventricular stroke volume measurements were performed by EV using an
Aesculon® monitor and TTE (either via trans-aortic valve flow velocity time integral [EVVTI], or via M-mode [EVMM]).
H0: bias was less than 10% and the mean percentage error (MPE) was less than 30% in Bland–Altman analysis
between EV and TTE. If appropriate, data were logarithmically transformed prior to Bland–Altman analysis.
Results: A total of 72 patients (age: 2 days to 17 years; weight: 0.8 to 86 kg) were analyzed. Patients were divided
into subgroups: organ transplantation (OTX, n =28), sepsis or organ failure (SEPSIS, n =16), neurological patients
(NEURO, n =9), and preterm infants (PREM, n =26); Bias/MPE for EVVTI was 7.81%/26.16%. In the EVVTI subgroup
analysis for OTX, NEURO, and SEPSIS, bias and MPE were within the limits of H0, whereas the PREM subgroup had a
bias/MPE of 39.00%/46.27%. Bias/MPE for EVMM was 8.07%/37.26% where the OTX and NEURO subgroups were
within the range of H0, but the PREM and SEPSIS subgroups were outside the range. Mechanical ventilation,
non-invasive continuous positive airway pressure ventilation, body weight, and secondary abdominal closure were
factors that significantly affected comparison of the methods.
Conclusions: This study shows that EV is comparable with aortic flow-based TTE for pediatric patients.Introduction
In the 1960s, impedance cardiography was developed to
monitor cardiac output (CO) [1]. This method is based
on a change in resistance during the cardiac cycle to a
transcutaneously applied electrical AC voltage, and is
used to calculate left ventricular stroke volume (LVSV),
and thus CO. After several modifications to the algorithm* Correspondence: m.blohm@uke.de
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unless otherwise stated.[1-5], impedance cardiography (that is, electrical velocimetry
(EV)) devices have become commercially available. There is
conflicting evidence on the use of EV in the literature
[6-12], and the technique is not yet widely used clinically.
This study evaluated continuously applicable and
non-invasive EV and compared it with discontinuously
applicable and non-invasive transthoracic echocardiography
(TTE). We compared LVSV measurements with EV and
TTE in pediatric and neonatal patients, and analyzed
parameters that affected comparison of the methods.Ltd. This is an Open Access article distributed under the terms of the Creative
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Study design
This single-center observational study aimed to validate
EV compared with TTE in pediatric intensive care patients
with normal cardiac biventricular anatomy. LVSV was
simultaneously measured by EV and TTE. Equivalence
of EV and TTE was assumed if Bland–Altman analysis
had bias <10% and mean percentage error (MPE) <30%
regarding LVSV measurement by EV compared with TTE
(H0) [13].
Electrical velocimetry measurements
An Aesculon® monitor (CE 0123; Osypka Medical,
Berlin, Germany) was used to record EV. The electrode
position of four RedDot® neonatal ECG radiolucent
prewired monitoring electrodes (3M Health Care,
Neuss, Germany) was chosen as recommended by the
manufacturer. The analyzed heart beats were recorded
simultaneously by TTE on the Aesculon® monitor.
The signal that was generated by the Aesculon® monitor
for EV LVSV measurements was accepted if the green
signal quality bar indicated a reliable signal.
Transthoracic echocardiography measurements
For echocardiography, either the GE Medical Systems
Vivid 7 (CE 0470; GE Healthcare, Munich, Germany) or
the GE Healthcare Technologies Logiq P5 (CE 0459; GE
Healthcare) ultrasound machine was used. LVSV by TTE
was calculated using two different methods [14,15]. In one
method, LVSV was calculated based on measurement of
the flow velocity time integral (VTI) measured over the
aortic valve (measured from an apical four-chamber view
with angle correction, if necessary) multiplied by the area
of the aortic valve:
LVSV ¼ aortic valve area  VTI
where the aortic valve diameter was determined by tripli-
cate measurements of the internal diameter of the aortic
valve hinge points:
Aortic valve area ¼ 0:5  diameterð Þ2  3:14
In the other method, LVSV was based on M-mode
measurement in the long parasternal axis, using the
internal algorithm of the echocardiography machine
based on the Teichholz equation [16]. For these M-mode
measurements, a single beat was simultaneously measured
in triplicate by TTE and EV.
Setting
Three consecutive heart beats for VTI measurements
or a single beat for the M-mode measurement were
simultaneously recorded with the corresponding identicalEV beats. All of the TTE measurements were performed
by a single operator (MEB).
Patients and sample characteristics
Pediatric and neonatal patients treated at the University
Medical Center Hamburg–Eppendorf (UKE) in the
pediatric and neonatal ICUs were eligible. This study was
approved by the ethics committee of the Chamber of
Physicians Hamburg, Germany. This study was performed
in accordance with the ethical standards laid down in the
1964 Declaration of Helsinki and its later amendments.
National laws were observed. Parental written informed
consent was obtained prior to data collection.
Data collection and statistics
The distribution of data was graphically assessed.
Right-skewed data were logarithmically transformed
prior to statistical analysis. The intra-class correlation for
repeated measurements on the same day in individual
patients was high (97% for comparison of EV versus the
LVSV measurement based on the VTI over the aortic
valve (EVVTI), 98% for comparison of EV versus the LVSV
determination by M-mode echocardiogram (EVMM)).
Data were therefore combined into 285 measurement pairs
(EV vs. TTE) by averaging the LVSV measured by each
method in an individual patient, thus representing a single
day of measurement in a single patient (n = 146 EVVTI
combined data points, n = 139 EVMM combined data
points). Agreement between the EV and TTE methods was
assessed by means of Bland–Altman plots [17,18]. The
MPE was computed as:
MPE ¼ precision = meanEV þ meanTTEð Þ = 2ð Þ
where precision was defined as the two-standard-
deviation method difference [13,17,19]. True precision
for EV (TPEV) was calculated based on the following
equation [20,21]:
TPEV ¼ √ MPEð Þ2– precisionTTEð Þ2
 
A mixed-model analysis (analysis of covariance)
was performed to identify the effects of persistent
ductus arteriosus (PDA), persistent foramen ovale, the
combination of PDA and persistent foramen ovale,
non-invasive continuous positive airway pressure (CPAP)
ventilation, any form of ventilation, use of catecholamines,
outcome, body weight, secondary abdominal closure,
sex, and heart rate on EV and TTE. Post-hoc power
analysis was performed and the least significant change
was calculated [20,22]:
Minimum change that needs to be measured by a
device to recognize a real change ¼ precision  √2
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surements was determined using Kendall's coefficient of
concordance. The statistical significance level was set to
0.05. SPSS version 20.0 (IBM, Armonk, NY, USA) was used
for all statistical analyses.
Results
The study cohort included 72 pediatric intensive care
patients (39 girls and 33 boys). The patients were
classified into four subgroups: solid organ transplantation
(OTX subgroup, n = 28: liver, n = 24; kidney, n = 2;
combined liver and kidney transplant, n = 2), sepsis
or other organ failure (SEPSIS subgroup, n = 16),
acute neurological patients (NEURO subgroup, n = 9), and
preterm infants (PREM subgroup, n = 26; gestational age
25 + 5 weeks to 34 + 5 weeks). Some patients (n = 7) could
be classified into two subgroups (NEURO and SEPSIS,
n = 5; OTX and SEPSIS, n = 2). In these 72 patients, 855
paired measurements of LVSV by EV and TTE (EVVTI,
438 paired measurements; EVMM, 417 paired measure-
ments) were recorded with two sets of measurements on
two separate days in most cases. In some patients, up to six
sets of measurements were taken on separate occasions
during their stay in the ICU. As described above, data were
combined into 146 EVVTI data points and 139 EVMM
data points, each representing a pair of measurements of
echocardiography versus impedance cardiography on a
single day in an individual patient. Table 1 presents detailed
information on the patient and sample characteristics.
The mean cardiac index was 4.0 l/(minute*m2) by EV,
compared with 4.2 l/(minute*m2) by LVSV measure-
ment based on the VTI over the aortic valve and with
4.5 l/(minute*m2) by LVSV determination by M-mode
echocardiogram. Because the study included two separateTable 1 Patient and sample characteristics of electrical veloci
855 paired measurements
Characteristic Total
Patients in each group (n) 72
Paired measurements (n) 855
Number of measurement days per patient (mean) 1.98
Weight (kg) (median/mean, range) 7.2/15.96
(0.84 to 86.00)
Age (years) (median/mean, range) 0.78/4.19
(0.01 to 17.87)
Use of inotropes (%) 29.47
Mechanical ventilation via endotracheal intubation (%) 39.30
Any form of respiratory support (that is,
non-invasive CPAP or ET tube) (%)
51.58
Secondary closure of the abdomen (%) 7.37
ICU survival rate (%) 85.61
Data are shown for the whole pediatric cohort and for subgroups. CPAP, continuou
patients subgroup; OTX, solid organ transplantation subgroup; PREM, preterm infanTTE methods compared with EV (based on transaortic
flow measurement (EVVTI) and M-mode measurement
(EVMM)) the results are presented separately for these
two study arms. There was a highly significant (P <0.001)
positive Pearson correlation of LVSV measurements by
EV and TTE for the whole cohort (EVVTI, r = 0.934;
EVMM, r = 0.896) and for subgroup analyses for OTX
subgroup (EVVTI, r = 0.929; EVMM, r = 0.869), SEPSIS
subgroup (EVVTI, r = 0.911; EVMM, r = 0.863) NEURO
subgroup (EVVTI, r = 0.955; EVMM, r = 0.899), and
PREM subgroup (EVVTI, r = 0.786; EVMM, r = 0.728).
Bland–Altman plots for EVVTI and EVMM are shown
in Figures 1 and 2. Outlying data points were not excluded
from the Bland–Altman analysis. Reasons for the outliers
are mentioned in Discussion. Bias and MPE are presented
in Table 2. For EVVTI, the whole cohort and all subgroups
(except for PREM subgroup) were within the cutoff levels
of H0. For EVMM, data were within the limits of H0 only
for OTX and NEURO subgroups, and outside the limits of
H0 for the whole cohort and the other subgroups.
The trend of the relative differences in LVSV measure-
ments over separate measurement occasions between the
two methods is shown in Figure 3. There was no correlation
between the relative differences and the times of individual
measurements (r = 0.101, P = 0.24), and this was observed
for the whole cohort and for combined data points with
separate analyses for EVVTI and EVMM.
Kendall’s coefficient of concordance (to assess trend
monitoring quality) did show a highly significant (P < 0.001)
concordance of the relative bias of 97% for EVVTI and
100% for EVMM. Looking at the three repetitive measure-
ments on individual measurement days, the concordance
for separate measurement days was 96% for EVVTI and
89% for EVVM.metry versus transthoracic echocardiography, based on
OTX SEPSIS NEURO PREM
28 16 9 26
372 213 96 243

















37.27 50.47 50.00 0.00
46.11 51.89 93.75 4.94
49.33 54.72 93.75 43.21
16.94 2.83 0.00 0.00
91.96 75.94 50.00 100.00
s positive airway pressure; ET, endotracheal; NEURO, acute neurological
ts subgroup; SEPSIS, sepsis or other organ failure subgroup.
Figure 1 Bland–Altman plot for comparison of left ventricular stroke volume measured by electrical velocimetry versus the
transthoracic echocardiography velocity time integral. Each data point represents combined paired measurements in an individual
patient that were measured on separate occasions (146 combined paired measurements, logarithmic scale). Bias and two standard deviations
(2SD) are shown as reference lines. EV, electrical velocimetry; LVSV, left ventricular stroke volume; MPE, mean percentage error; TTE,
transthoracic echocardiography; VTI, velocity time integral.
Figure 2 Bland–Altman plot for comparison of left ventricular stroke volume measured by electrical velocimetry versus the
transthoracic echocardiography M-mode. Each data point represents combined paired measurements in an individual patient measured on
separate occasions (139 combined paired measurements, logarithmic scale). Bias and two standard deviations (2SD) are shown as reference lines.
EV, electrical velocimetry; LVSV, left ventricular stroke volume; MPE, mean percentage error; TTE, transthoracic echocardiography.
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Table 2 Comparison of measurement of left ventricular
stroke volume by electrical velocimetry versus transthoracic
echocardiography using Bland–Altman analysis
Study arm Group Number of patients/
measurements
Bias (%) MPE (%)
EVVTI All 72/146 7.81 26.16
OTX 28/65 5.05 23.03
SEPSIS 16/36 2.62 26.82
NEURO 9/16 6.98 14.79
PREM 26/41 39.00 46.27
EVMM All 72/139 8.07 37.26
OTX 28/59 5.04 28.96
SEPSIS 16/35 2.57 43.53
NEURO 9/16 6.65 27.10
PREM 26/40 39.53 42.80
Data were analyzed for subgroups. EVMM, electrical velocimetry versus the
transthoracic echocardiography M-mode; EVVTI, electrical velocimetry versus
the transthoracic echocardiography velocity time integral; MPE, mean
percentage error; NEURO, acute neurological patients subgroup; OTX, solid
organ transplantation subgroup; PREM, preterm infants subgroup; SEPSIS,
sepsis or other organ failure subgroup.
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measurements was 7.97% and that in M-mode measure-
ments was 7.42% based on the calculation described by
Cecconi and colleagues [20] with lower precision in the
PREM subgroup (LVSV measurement based on the VTI
over the aortic valve 29.55%/LVSV determination byFigure 3 Trend of left ventricular stroke volume measurements using
velocity time integral over the aortic valve. Percentage difference in rep
methods in individual patients on serial measurement days. Box plots show th
points were included; outliers from Figure 1 were excluded). Note the consta
echocardiography; EV, electrical velocimetry; VTI, velocity time integral.M-mode echocardiogram 25.07%). TPEV was 24.92% for
EVVTI and 36.51% for EVMM. Subgroup analysis for
EVVTI showed a better TPEV for the more homogeneous
patient subgroups OTX (22.22%) and NEURO (12.12%)
compared with SEPSIS (26.75%) and PREM (35.60%).
Post-hoc power analysis showed that the sample size was
sufficient to detect a percentage difference in LVSV
measurements of 9% for EVVTI and 12% for EVMM
(at power = 0.8 and P = 0.05).
A mixed-model analysis was performed to identify
parameters affecting any differences between EV and
TTE (Table 3). A significant effect (for one or both of
the comparisons EVVTI and EVMM) was observed
for weight, secondary abdominal closure, endotracheal
mechanical ventilation, and non-invasive nasal CPAP
ventilation in the PREM subgroup. There tended to
be an effect of sex on differences between EV and TTE
(P = 0.062). Heart rate, outcome, and catecholamine
use did not lead to a significant effect on differences
between EV and TTE. In the PREM subgroup, CPAP
ventilation (37% of the data points in the PREM subgroup
were measured with CPAP) significantly (P = 0.022)
affected EVVTI, but this effect was not observed for
EVMM. For isolated PDA (5% of the data points for
the PREM subgroup were with PDA) a trend was observed
(P = 0.077 in EVVTI), but there was no effect of PDA in
EVMM. There was no significant effect of a persistent
foramen ovale in the PREM subgroup.electrical velocimetry versus measurements based on the
eated left ventricular stroke volume (LVSV) measurements between
e median, standard deviation, and outliers (136 combined measurement
nt average direction of bias over repeated measurement days. TTE,
Table 3 Possible parameters that affect differences in








Non-invasive CPAP in PREM EVVTI 40.1 (34.6/46.4) 0.022
EVMM 31.6 (26.6/37.6) 0.732
Ventilation via ET tube EVVTI 5.0 (4.3/5.9) 0.017
EVMM 4.7 (4.0/5.7) 0.069
Body weight EVVTI 9.5 (6.4/7.5) <0.001
EVMM 11.5 (9.7/13.5) <0.001
Secondary abdominal closure EVVTI 5.2 (4.4/6.1) 0.272
EVMM 6.9 (5.5/8.7) 0.002
CPAP, continuous positive airway pressure; ET, endotracheal; EVMM, electrical
velocimetry versus the transthoracic echocardiography M-mode; EVVTI, electrical
velocimetry versus the transthoracic echocardiography velocity time integral;
PREM, preterm infants subgroup.
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The main result of the study was good agreement for
Bland–Altman analysis for EVVTI, with an acceptably
low bias <10%, and MPE <30% [13] in the whole cohort
and in the OTX, NEURO, and SEPSIS subgroups.
However, bias and MPE in the PREM subgroup were
above the accepted range. For EVMM, bias was within the
range of H0 except in the PREM subgroup. For EVVM,
MPE was above the range of H0 in the whole cohort and
the PREM and SEPSIS subgroups (not OTX and NEURO)
(Table 2).
A theoretical TPEV could be calculated because two
imprecise CO monitoring methods (EV and TTE) were
compared [19-21]. In our study, this TPEV was based on
combined data points with triplicate measurements.
TPEV was better for the OTX and NEURO subgroups
than for the less homogeneous subgroups SEPSIS
and PREM. These findings are consistent with other
validation studies on EV. Acceptable equivalence was
reported [13] when comparing EV with other CO
monitoring methods in homogeneous adult biventricular
patients [9] and homogeneous pediatric patient groups
[23,24]. Non-equivalence of EV compared with other
methods (mostly due to a high MPE) has been reported in
studies with homogeneous and heterogenic pediatric
patient cohorts [21,25-29], with an effect of left-to-right
shunts and ventricular septal defects on the compared
methods [27], as well as in adult studies with heterogenic
patient cohorts [11,12,30-32].
Transthoracic impedance is affected by air and fluid
content in the chest. Changes in fluid content in the
chest by pleural effusion, cardiac congestion, alterations
in the size of cardiac chambers (for example, because
of valvular insufficiency), or increased air content (for
example, by application of CPAP or mechanical ventilation)affect basic impedance, and thus calculation of LVSV by
EV. Changes in blood content or blood flow alter the
size of the cardiac cycle-related change in impedance
(for example, in cardiac valve insufficiency or in the
presence of a relevant PDA). The outliers in the
Bland–Altman plots in Figures 1 and 2 had one or
several of the abovementioned factors limiting signal quality
in EV (for example, Patient A had mitral endocarditis
with mitral insufficiency (grade 4), Patient B was on
high-frequency oscillation after bone marrow transplant-
ation, and Patients C, D, and E all had organ transplant with
abdominal patch closure or a large intraabdominal tumor
prior to liver transplantation). These findings are consistent
with a previous study showing a significant effect of
extravascular lung water on impedance cardiography [33].
Mixed-model analysis was performed on parameters
that theoretically affect the true LVSV and CO and/or
impedance cardiography measurements. Parameters that
affected differences between the methods of EV and TTE
in this study were body weight, mechanical ventilation,
and non-invasive CPAP ventilation. Inotropic support or
outcome did not affect differences between EV and TTE.
The parameter with the strongest effect was non-invasive
CPAP ventilation, which contributed to 40.1% of the
difference using EVVTI in the PREM subgroup. This
result and our finding that PDA was present in only
5% of PREM measurements may have been the reason
why PDA did not reach significance (P = 0.077) in the
PREM group. A previous study compared CO by EV
versus TTE in 28 preterm neonates, and showed that
the difference between the methods was 4% for ventilated
infants and 2.5% for nonventilated infants [23]. This
previous finding is in accordance with the current
study, which demonstrated an effect of ventilation on
comparison of the methods.
Theoretical limitations of the study
To achieve a simultaneously paired LVSV measurement of
identical heart beats by EV and TTE, the echocardiography
used in the present study was only in a single plane rather
than in two opposing planes. The precision of TTE in this
study might therefore not have been as good as 30%, which
has been reported in the literature [19]. However, the
precision of TTE might have been better than the
MPE of 36% reported in children for systems with blind
Doppler probe positioning [34,35]. The precision of TTE
in this study was calculated as approximately 8%.
Additionally, the precision of TTE was not homogeneous
and depended on patient subgroups with lower precision,
particularly in the PREM subgroup, contributing to higher
bias and MPE in that subgroup.
Another limitation of the study may be due to variation
in LVSV during the respiratory cycle. Our study used
paired measurements irrespective of the respiratory cycle,
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stroke volume was between 10 and 30% in most
cases. In vigorously breathing neonates, the variation
was as high as 40% (as indicated by the Aesculon®
monitor). The variation in stroke volume during the
respiratory cycle is a problem for any method of
determining CO [26,30,36,37]. Theoretically, variation
in stroke volume should equally affect EV and TTE.
Previous studies have shown a significant effect of
extravascular lung water on impedance cardiography
CO measurements based on the Sramek–Bernstein
equation compared with CO by thermodilution [33].
This implies that heterogenic patients with different
amounts of extravascular lung water (as in this study)
have heterogenic EV measurements, and this will affect
comparison of EV and TTE.
Trend monitoring
To base goal-directed therapy on a monitoring tool such
as EV CO measurement, the capacity of the applied
method for determining a trend is important [20,38]
(that is, the ability of the method to detect a change
in CO over time). Figure 3, which shows repeated
measurements over time, demonstrates that the average
direction of bias between EV and TTE remained positive
or negative with repeated measurements. The high
Kendall’s concordance mathematically supports this visual
estimate of the constancy of the bias both for repetitive
tests on the same day and on different days. By increasing
the sampling interval with more measurements or more
heart beats, the MPE between the two compared methods
will become less (that is, precision will improve) [20,22].
The least significant change is defined as the minimum
change that needs to be measured by a device to recognize
a real change [22]. According to the equation for calculating
the least significant change, the minimum percentage of
LVSV change detected by EV in this study was 11.3%
(sampling interval of three heart beats). After five
measurement cycles (equivalent to 15 heart beats),
the least significant change for EV would theoretically
[22] become 5%. This implies that at a heart rate of
60 beats/minute EV would theoretically be able to detect a
5% change in LVSV within 15 seconds of averaged
measurement. This short time response to a relatively
small change in LVSV implies good tracking properties of
the EV method [38]. Other continuous CO monitoring
devices, including non-invasive devices (for example,
continuous Doppler-based systems) [34,35] and invasive
devices (for example, transpulmonary thermodilution
methods combined with pulse contour analysis) [11,12],
normally average multiple cardiac cycles for more accurate
continuous monitoring. Because EV is a non-invasive and
continuously applicable method, combined measurement
cycles averaging LVSV and CO over multiple heart beatsare technically possible. This averaging would also equalize
variation in stroke volume during the respiratory cycle. EV
therefore appears to be suitable for monitoring trends. The
advantages of non-invasiveness and continuity of EV, with
a low bias compared with TTE, may outweigh the relatively
low precision of this method.
In summary, LVSV measurements by EV and TTE
were not different in pediatric intensive care patients if
LVSV was determined by TTE using transaortic flow
(EVVTI). This finding was observed for the whole
cohort and for the subgroups OTX, NEURO, and
SEPSIS, but not for the PREM subgroup. This equivalence
could not be demonstrated because of a high MPE for EV
and TTE if LVSV was determined by M-mode (EVMM),
except in the OTX and NEURO subgroups. The poorer
agreement between EV and TTE in the PREM subgroup
may be related to the fact that nasal CPAP was the main
parameter that affected differences between the methods.
Because the average direction of bias between EV and
TTE with repeated measurements in the same patients
remained constant, EV appears to be a suitable method
for following trends in CO.
Conclusions
Because of partial or good agreement between the two
methods EV and TTE for determining LVSV (depending
on the group of patients), EV appears to be suitable
for determination of CO in children. The advantage
of continuous applicability theoretically facilitates the
possibility of monitoring of CO trends by EV.
Key messages
 In this study, stroke volume measurements based on
EV and echocardiographic transaortic flow were not
different in pediatric intensive care patients.
 In preterm infants, there was a difference between
the two methods, but LVSV measurements were
significantly correlated.
 The main factors that affected comparison between
EV and echocardiography were any form of
ventilation and body weight.
 EV appears to be suitable for monitoring trends in
pediatric patients.
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